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Background: The Western-style diet is characterised by the high intake of energy-
-dense foods. Consumption of either high-fructose diet or saturated fat resulted in 
the development of metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) 
is the hepatic manifestation of the metabolic syndrome. Many researchers studied 
the effect of high-fat diet (HFD), high-fructose diet (HFruD) and high-fructose 
high-fat diet (HFHF) on the liver. The missing data are the comparison effect of 
these groups i.e. are effects of the HFHF diet on the liver more pronounced? So, 
this study was designed to compare the metabolic and histopathological effect 
of the HFD, HFruD, and HFHF on the liver. The proposed underlying mechanisms 
involved in these changes were also studied.
Materials and methods: Twenty four rats were divided into four groups: con-
trol, HFD, HFruD, and HFHF. Food was offered for 6 weeks. Biochemical, light 
microscopic, immunohistochemical (Inducible nitric oxide synthase [iNOS] and 
alpha-smooth muscle actin [α-SMA]), real-time polymerase chain reaction (gene 
expression of TNF-α, interleukin-6, Bax, BCL-2, and caspase 3), histomorphometric 
analysis and oxidative/antioxidative markers (thiobarbituric acid reactive substances 
[TBARS], malondialdehyde [MDA]/glutathione [GSH] and superoxide dismutase 
[SOD]) were done.
Results: The HFD, HFruD and HFHF groups developed a cluster of liver disorders; 
steatosis, necrosis, inflammation, apoptosis, ballooning degeneration and cytopla-
smic vacuolations. Internal metabolic impairments include elevated serum levels of 
glucose, triglycerides, low density lipoprotein and decreased serum levels of high 
density lipoprotein and albumin. The immunoreaction of the α-SMA and iNOS 
was strong in these groups. The oxidant markers (MDA and TBARS) were elevated, 
while the antioxidant markers (SOD and GSH) were decreased. The area per cent 
of collagen, inflammatory markers, caspase 3 and Bax were elevated, while the 
BCL-2/Bax ratio was decreased. The decrease in PAS, antioxidant markers and the 
elevation of the α-SMA, iNOS, inflammatory and oxidant markers were obvious 
in the HFHF when compared to that of the other groups.
Conclusions: High-fat diet, HFruD, and HFHF developed morphologic hepatic 
changes ranging from steatosis to necrosis and inflammation, besides the deve-
lopment of internal metabolic impairments. The chief factors of hepatic injury 
were fat accumulation in the hepatocytes, oxidative stress and highly elevated 
iNOS. Compared to the other groups, HFHF’s effect was more prominent. (Folia 
Morphol 2019; 78, 1: 124–136)
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INTRODUCTION
The Western-style diet is characterised by the high 
intake of energy-dense foods [19]. High-fructose corn 
syrup and saturated fats are two chief elements in 
this diet [19]. Consumption of either these two el-
ements resulted in the development of metabolic 
syndrome (MS), which includes: insulin insensitivity, 
higher circulating triglycerides (TG) and weight gain 
from increased body fat [6]. In addition, the nutrition 
above the packing capability of adipose tissue results 
in precipitation of TG in different organs, causing 
steatosis and even organ dysfunction [38]. Moreover, 
high consumption of carbohydrates with or without 
fats increases the risk of obesity and diabetes [25]. 
Non-alcoholic fatty liver disease (NAFLD) is the com-
monest sort of liver diseases in the Western countries 
[21]. It is the hepatic manifestation of the MS which 
represents the major cause of liver-related morbidity 
and mortality [3]. It has a large scale, starting from 
simple fatty liver and extending to non-alcoholic ste-
atohepatitis (NASH) [20].
Understanding the mechanisms for NASH is the key 
to apply real preventive and/or treatment approaches 
against this disease. There are many proposed mech-
anisms such as oxidative stress, TG accumulation, 
inflammation and apoptosis [12, 13, 15, 33].
The worldwide increments in the patient with 
MS have drawn the researchers’ attention to intro-
ducing an experimental model that resembles the 
human [9]. Animal models fed with 40–60% high-
fat diet develop insulin resistance, intrahepatic fat 
deposition, obesity and metabolic parameters close 
to human NASH [8]. 
Many researchers studied the effect of high-fat 
diet (HFD), high-fructose diet (HFruD) and high-fruc-
tose high-fat diet (HFHF) on the liver [21, 22, 39]. 
The missing data are the comparison effect of these 
groups i.e. are effects of the HFHF diet on the liver 
more pronounced? So, this study was designed to 
compare the metabolic and histopathological ef-
fect of the HFD, HFruD, and HFHF on the liver. The 
proposed underlying mechanisms involved in these 
changes were also studied.
MATERIALS AND METHODS
Twenty-four Sprague-Dawley adult male albino 
rats were acclimatised in the laboratory for a period 
of 2 weeks before carrying out the experiment. The 
rats were kept in cages at an ambient temperature 
of 26°C ± 2°C with 12 h light and 12 h dark cycle. 
The animals were observed twice per day for signs of 
morbidity and mortality. The general toxicological data 
were recorded, including the motility, food and water 
consumption, health status and body weight gain.
The rats were divided into four equal groups 
(6 rats each):
 — Control group: this group was given standard 
commercial diet (5.8% kcal of fat and 44.3% kcal 
carbs) [41];
 — HFD group: this group was given ad lib water and 
high-fat chow which contained 60% kcal/g of 
fat, 20% kcal/g of carbohydrate from corn starch 
(Product #: D08060104, Research Diets, Inc., New 
Brunswick, NJ) [41];
 — HFruD group: this group was given ad lib wa-
ter and high-fructose chow which was 55% 
kcal/g of fructose, 10% kcal/g of fat (Product #: 
D05111802, Research Diets, Inc., New Brunswick, 
NJ) [41]. The rats were fed HFruD containing soy-
bean oil to avoid the development of glucose 
intolerance [32];
 — HFHF group: this group was given ad lib water and 
a diet containing 45% kcal/g of fat, 30% kcal/g 
of fructose [21].
Food and water were offered all the time for 
6 weeks.
Body weight and food consumption 
measurements
Rats’ body weight was measured at the begin-
ning, then every week and just before sacrificing 
them. Their food consumption was measured on 
a daily basis.
The rats were sacrificed 24 h after the 6 weeks’ 
experimental period. The liver specimens were excised 
and fixed in 70% alcohol, trimmed, washed, dehy-
drated in ascending grades of alcohol, cleared in xylol 
and processed for paraffin sections of 5 µm thickness.
Light microscopic study
Hematoxylin and eosin (H&E) stain
Masson’s trichrome stain. For the demonstra-
tion of collagen fibres, the technique of Masson’s 
trichrome stain was done according to Sheehan [30]. 
The paraffin sections were dewaxed, rehydrated then 
stained in acid fuchsin solution for 5 min, rinsed in 
distilled water, placed in phosphomolybdic acid solu-
tion for 3 min, washed in distilled water, stained with 
methyl blue solution for 2–5 min, rinsed in distilled 
water, and treated in acetic acid for 2 min. Finally, the 
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sections were dehydrated in absolute alcohol, cleared 
in xylol and mounted in Canada balsam. The nuclei 
appeared dark red, the cytoplasm appeared pale red 
and the collagen fibres appeared blue. 
Histochemical evaluation (PAS stain)
The paraffin sections were dewaxed, rehydrat-
ed and then oxidised in 1% of periodic acid for 
5 min. Then, they were washed with distilled water, 
treated with Schiff’s reagent for 15 min, washed in 
running tap water for 5–10 min, counterstained in 
Harri’s haematoxylin for 5 min, differentiated in 1% 
acid-alcohol, washed well in tap water, dehydrated 
in ascending grades of absolute alcohol, cleared 
in xylene, and mounted in Canada balsam. Glyco-
gen and other reactive carbohydrates appeared 
magenta.
Analysis of the blood parameters
Blood samples were collected into serum-sepa-
rating tubes at the end of the experiment, following 
a 12-h overnight fast. The samples were centrifuged 
at 3000 rpm for 15 min at 4°C. Serum was stored at 
–70°C until used in assays. Triglyceride (TG, mg/dL), 
cholesterol (mg/dL), high density lipoprotein (HDL, 
mmol/L); low density lipoprotein (LDL, (mmol/L), al-
bumin (g/dL) and glucose (mmol/L) levels were de-
termined using commercial kits (Asan Co. Ltd., Seoul, 
Korea).
Extraction and measurement 
of hepatic triglycerides
Total lipid was extracted from the liver by homog-
enizing with chloroform-methanol mixture (2:1, v/v) 
to a final dilution 20-fold the volume of the tissue 
sample [16]. The extraction was done in a tissue for 
3 times. Pooled extract was dried using nitrogen evap-
orator. Hepatic TG were determined by colorimetric 
enzymatic assays [29].
Immunohistochemical study
The paraffin sections were dewaxed, rehydrated 
and incubated with 3% hydrogen peroxide solution 
for 30 min and endogenous peroxidase activity was 
blocked. Then, heat mediated antigen retrieval was 
performed and a microwave was utilised for tissue 
antigen retrieval. The sections were cleaned and put 
into phosphate buffered saline (PBS) for 5 min. After 
PBS was wiped off, the appropriate amount of serum 
was added to the sections at room temperature for 
30 min. All techniques were done according to the 
manufacturer’s instructions.
Inducible nitric oxide synthase. The sections 
from each paraffin block were incubated with a reac-
tion buffer containing primary antibody anti inducible 
nitric oxide synthase (iNOS) antibody (ab15323 at 
a dilution of 1:100) for at least 14 h at 4°C. Afterward, 
the sections were incubated with Goat anti-Rabbit 
IgG H&L (HRP) (ab205718) for 20 min at 37°C. Each 
step was followed by adequately washing with PBS.
Alpha-smooth muscle actin. The alpha-smooth 
muscle actin (α-SMA) was performed to evaluate the 
degree of fibrosis [4]. The sections from each paraffin 
block were incubated with a reaction buffer contain-
ing primary antibody α-SMA antibody {(1A4) (ab7817) 
1:100}. Afterward, the sections were incubated 
with Goat anti-Rabbit IgG H&L (HRP) (ab205718) for 
20 min at 37°C. Each step was followed by adequately 
washing with PBS.
Oxidative/antioxidative markers 
in liver homogenates
Oxidative stress markers. Thiobarbituric acid 
reactive substances (TBARS) and malondialdehyde 
(MDA) were measured according to Tipple and Rogers 
[36]. This method measures the colour produced by 
the reaction of the thiobarbituric acid (TBA) with lipid 
peroxides, TBARS at 532 nm. 100 mg of tissue was 
homogenised and precipitated with equal volume 
of 8.1% sodium dodecyl sulphate, 20% acetic acid 
solution adjusted to pH 7.4 in 1 mL PBS. 0.8% TBA 
solution was added to the liver tissue homogenate to 
precipitate the protein and then centrifuged. Super-
natants were collected and TBA solution was added 
to the supernatants. After boiling for 10 min in water 
bath, the absorbance was measured. 
Anti-oxidative markers. Tissue glutathione (GSH) 
content was measured according to Tipple and Rogers 
[36]. The measurement of GSH is based on the reduc-
tion of 5, 5 dithiobis (2-nitrobenzoic acid) (DTNB) with 
reduced glutathione to produce a yellow compound. 
The reduced chromogen is directly proportional to GSH 
concentration and its absorbance is measured at 405 nm 
by using a commercial kit (Biodiagnostic, Egypt).
The superoxide dismutase (SOD) activity in liver 
homogenate was measured according to Weydert and 
Cullen [40] by the inhibition of nitroblue tetrazolium 
reduction by O2-generated by the xanthine/xanthine 
oxidase system. One unit is the amount of SOD that 
inhibits the rate of formazan dye formation by 50%.
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Image analysis and morphometric measurements
The optical density of PAS and area per cent of 
collagen fibres and immune expression of iNOS and 
α-SMA were done using Leica LAS V3.8 image analys-
er computer system (Switzerland). The measurements 
were obtained by an independent blinded observer. 
The data was obtained in ten non-overlapping mi-
croscopic fields taken randomly from each slide and 
were examined within the standard measuring frame, 
using a magnification of ×400. Within the measuring 
frame, the area per cent were detected and masked 
by a binary colour.
Real-time polymerase chain reaction (PCR) 
(gene expression of TNF-α, IL-6, Bax, BCL-2, 
and caspase 3)
Total RNA extraction. Total RNA was extracted 
from the thyroid tissue using the TRIzol method ac-
cording to the manufacturer’s protocol (Invitrogen, 
Life Technologies, Waltham, MA, USA). In brief, RNA 
was extracted by homogenisation in a TRIzol reagent. 
The homogenate was then incubated for 5 min at 
room temperature. A 1:5 volume of chloroform was 
added, and the tube was vortexed and centrifuged at 
12,000 g for 15 min. Thereafter, the aqueous phase 
was isolated, and the total RNA was precipitated with 
absolute ethanol. After centrifugation and washing, 
the total RNA was finally diluted in 20 µL of the RNase-
free water. The RNA concentrations and purity were 
measured with an ultraviolet spectrophotometer at 
260 nm.
Complementary DNA (cDNA) synthesis. The 
cDNA was synthesized from 1 mg RNA using Super-
script III First-Strand Synthesis; a system as described 
in the manufacturer’s protocol (Invitrogen, Life Tech-
nologies). In brief, 1 µg of total RNA was mixed with 
50 µM oligo (DT) 20, 50 ng/µL random primers, and 
10 mM dNTP mix in a total volume of 10 µL. The 
mixture was incubated at 56°C for 5 min and then 
placed on ice for 3 min.
The reverse transcriptase master mix containing 
2 µL of 10× RT buffer, 4 µL of 25 mM MgCl2, 2 µL of 
0.1 M DTT, and 1 µL of SuperScript® III RT (200 U/µL) 
was added to the mixture and was incubated at 25°C 
for 10 min followed by 50 min at 50°C.
Real-time quantitative PCR. The relative abun-
dance of mRNA species was assessed using the SYBR 
Green method on an ABI prism 7500 sequence detec-
tor system (Applied Biosystems, Foster City, CA, USA). 
PCR primers were designed with Gene Runner Soft-
ware (Hasting Software, Inc., Hasting, NY, USA) from 
RNA sequences from Gen Bank. All primer sets had 
a calculated annealing temperature of 60°. Real-time 
quantitative PCR was performed in a 25-µL reaction 
volume consisting of 2X SYBR Green PCR Master Mix 
(Applied Biosystems), 900 nM of each primer and 
2–3 µL of cDNA. Amplification conditions were 2 min 
at 50°, 10 min at 95° and 40 cycles of denaturation 
for 15 s and annealing/extension at 60° for 10 min. 
Data from RT assays were calculated using the v1·7 
Sequence Detection Software from PE Biosystems 
(Foster City, CA). Relative expression of studied gene 
mRNA was calculated using the comparative Ct meth-
od. All values were normalised to the b-actin gene 
and reported as fold change (Table 1).
Statistical analysis
Statistical analysis was performed using statisti-
cal package for the social sciences statistical software 
(SPSS) version 21.0 (IBM Corporation, Somers, NY, USA). 
The data were expressed as means ± standard deviation 
(SD). Statistical evaluation was done using one-way 
analysis of variance (ANOVA) followed by Bonferroni 
pairwise comparisons. Significance was considered 
when the p-value was ≤ 0.05. The percentage of in-
crease or decrease (difference) in all study parameters 
Table 1. The primers sequence for the studied genes
Isoform Forward primer Reverse primer
TNF-α 5′- TGAGATTCGTGCACAAGAGG-3′ 5′- GTCATGGCTTTGGATGTCCT-3′
b-actin 5’-CTTTGATGTCACGCACGATTTC -3’ 5’- GGGCCGCTCTAGGCACCAA-3’
IL-6 5’-GCCCTTCAGGAACAGCTATGA-3’ 5’-CATCAGTCCAAGAAGGCAACT-3’
Caspase 3 5’-TTCAGAGGGGATCGTTGTAGAAGTC-3’ 5’- CAAGCTTGTCGGCATACTGTTTCAG-3’
Bax 5’-CTGAGCTGACCTTGGAGC -3’ 5’- GACTCCAGCCACAAAGATG-3’
BCL-2 5’-GACAGAAGATCATGCCGTCC -3’ 5’- GGTACCAATGGCACTTCAAG-3’
TNF-α — tumour necrosis factor alpha; Il-6 — interleukin 6
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were calculated per the following formula: Percentage 
of difference = (mean difference value between two 
groups) / (value of the compared group) × 100.
RESULTS 
The general toxicological data (Table 2)
No mortalities were observed in all studied groups. 
The motility, food and water consumption and health 
status were relatively good. 
The body weight at the beginning of the study was 
149.0 ± 3.6 g. At the end of the study, the animals 
of all studied groups gained weight; their mean body 
weights increased by 15%, 24.7%, and 23.5% in the 
HFD, HFruD and HFHF groups as compared to that of 
the control group. A non-significant difference was 
observed in the HFD, HFruD and HFHF groups when 
compared to each other. 
The general structure of the liver 
as shown by H&E staining
The liver of the control group exhibited the normal 
histological architecture around the central vein  (Fig. 1A). 
The HFD, HFruD and HFHF groups exhibited differ-
ent forms of hepatic necrosis: pyknosis, karyorrhexis, 
and karyolysis. Hepatocytes with apoptosis, steatosis 
(microvesicular and macrovesicular) and cytoplasmic 
vacuolations were also detected in these groups. 
Hepatocytes with ballooning degeneration were only 
identified in the HFD and HFHF groups (Fig. 1B–E).
The portal area of the control rat was presented with 
the normal histological pattern (Fig. 2A). The portal veins 
of the three experimental Western diet groups were 
dilated and congested with interrupted endothelium. 
Inflammatory cellular infiltrations with steatosis (mi-
crovesicular and macrovesicular) around the periportal 
areas were also realized in these groups (Fig. 2B–D).
The content of collagen fibres
The collagen fibres around the periportal area 
were minimum in the control group (Fig. 3A). Colla-
gen tissue fibres increased by 310% (3 folds), 306% 
(3 folds) and 229% (2 folds) in the HFD, HFruD and 
HFHF groups when compared to that of the control 
group (Fig. 3B–D, Table 3). Non-significant differences 
were observed between the HFD, HFruD and HFHF 
groups when compared to each other.
Histochemical evaluation (PAS stain)
A strong PAS reaction was observed in the control 
group (Fig. 4A). The reaction displayed 36%, 48%, and 
60% significant decrease when compared to that of 
the control group. The decrease in the HFHF group 
was 47% and 30.7% compared to that of the HFD, 
HFruD groups (Fig. 4B–D, Table 3).
Immunohistochemical evaluation
The reaction of the α-SMA was slight in the control 
group (Fig. 5A). When comparing the HFD, HFruD 
and HFHF groups with the control group, there were 
significant elevations in the mean area per cent of the 
α-SMA by 433% (4 folds), 173% (1.7 folds) and 750% 
(7.5 folds), respectively. The elevation in the HFHF 
group was 56% and 210% compared to that of the 
HFD, HFruD groups (Fig. 5B–D, Table 3). 
The iNOS reaction was absent in the control group 
(Fig. 6A). Such reaction presented high elevation in 
the HFD, HFruD and HFHF groups by 767% (7.6 folds), 
903% (9 folds) and 1458% (14 folds), respective-
ly when compared to that of the control group. 
The elevation in the HFHF group was 84.6% and 
255% compared to that of the HFD, HFruD groups 
(Fig. 6B–D, Table 3).
Biochemical evaluation (Table 4)
Regarding the hepatic TG, there was a significant 
rise in their mean values by 83%, 50% and 112% in 
the HFD, HFruD and HFHF groups, respectively com-
pared to that of the control group.
The mean values of the serum TG in the HFD, 
HFruD and HFHF groups revealed 59%, 40%, and 76% 
significant increase, respectively, when compared to 
that of the control group. At the same time, the mean 
Table 2. The mean of the body weight (BW) gain in the different 
experimental groups
Group BW Versus group P
Control 170.0 ± 5.0
HFD 200.7 ± 10.1 Control 0.044*
HFruD 1.000
HFHF 1.000
HFruD 212.0 ± 4.0 Control 0.007*
HFD 1.000
HFHF 1.000
HFHF 210.0 ± 17.3 Control 0.010*
HFD 1.000
HFruD 1.000
Data are shown as mean ± standard deviation. 
The body weight at the beginning of the study was 149.0 ± 3.6 g. 
*p-value significant; other abbreviations — see text
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values of the cholesterol of the HFD, HFruD and HFHF 
groups showed 58%, 42%, and 87% significant rise, 
when compared to that of the control group.
On the other hand, the mean levels of HDL in 
the HFD, HFruD and HFHF groups was significantly 
decreased by 59%, 47%, and 59%, compared to that 
of the control group. 
The mean LDL values in the HFD, HFruD and HFHF 
groups displayed 180%, 135% and 238% significant 
upsurge respectively when compared to that of the 
control group.
When comparing the HFD, HFruD and HFHF 
groups with the control group, there was a signif-
icant decrease in the mean values of albumin (by 
29%, 20%, and 45%, respectively) and a significant 
increase in the mean glucose level (by 85%, 105%, 
and 122%, respectively).
Inflammatory and oxidative/antioxidative 
markers’ evaluation (Table 5)
The mean values of the tumour necrosis factor 
alpha (TNF-α) in the HFD, HFruD and HFHF groups 
were 126% (1.26 folds), 190% (1.9 folds) and 229% 
(2.29 folds) higher than in the control group. The 
elevation in the HFHF group was 45.6% and 13.2% 
compared to that of the HFD, HFruD groups.
Figure 1. Liver sections around central veins in different groups; A. Central vein (CV) and sinusoids (S) with Von-Kupffer cells (arrows). The 
hepatocytes (H) and nuclei (N) with central nucleolus. Some hepatocytes are binucleated (B) in a rat of the control group; B. Hepatocytes with 
apoptosis (arrowheads) and hepatocytes with ballooning degeneration (M). Nuclear necrosis in the form of pyknosis (arrows) and karyolysis 
(curved arrows). Note dilated sinusoids (S) and microvesicular steatosis (V) in a rat of the high-fat diet group; C. Hepatocytes with pyknotic 
nuclei (arrows) and with ballooning degeneration (B). Note microvesicular steatosis (arrowheads) and macrovesicular steatosis (M) in a rat of the 
high-fat diet group; D. Hepatocytes with apoptosis (arrowheads) and degenerated hepatocytes with rarefied cytoplasm (R) in a rat of the HFruD 
group. Note pyknosis (arrows) and signet ring nuclei (curved arrow) with intrahepatic vacuolations (V); E. Hepatocytes with rarefied cytoplasm 
(R), apoptosis (arrowheads), karyolysis (curved arrows) and karyorrhexis (k). Note ballooning hepatic degeneration (arrows) and microvesicular 
steatosis (V) in a rat of the HFHF group. Haematoxylin and eosin staining. Scale bars = 50 µm, total magnification ×400.
A
C
E
B
D
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Figure 2. Liver sections around the portal area in different groups. Note: portal vein radicle (PV), hepatic artery (H) and bile ductule (BD) lined 
with cuboidal epithelium; A. A rat of the control group; B. Dilated congested portal vein (PV) with interrupted endothelium, inflammatory cellular 
infiltrations (arrows), microvesicular steatosis (curved arrows) and macrovesicular steatosis (M) in a rat of the high-fat diet group; C. A dilated 
congested portal vein (PV), inflammatory cellular infiltrations (arrows), microvesicular steatosis (curved arrows) and apoptosis (arrowheads) in 
a rat of the HFruD group; D. A dilated portal vein (PV), inflammatory cellular infiltrations (arrows) and apoptosis (arrowhead) in a rat of the HFHF 
group. Haematoxylin and eosin staining. Scale bars = 50 µm, total magnification ×400.
Figure 3. Collagen fibres (arrows) around the periportal area in different groups; A. Minimal amount of collagen fibres in the control group; 
B–D. Increased amount of collagen fibres in the HFD, HFruD and HFHF groups, respectively. Masson’s trichrome staining. Scale bars = 50 µm, 
total magnification ×400.
A B
C D
A B
C D
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The mean values of the interleukin 6 (IL-6) in the 
HFD, HFruD and HFHF groups showed 230% (2.3 
folds), 383% (3.83 folds) and 426% (4.26 folds) el-
evation, respectively, when compared to that of the 
control group. The elevation in the HFHF group was 
59.3% when compared to that of the HFD group.
The mean levels of MDA in the HFD, HFruD and 
HFHF groups were significantly increased by 526% 
(5.26 folds), 746% (7.46 folds) and 1000% (10 folds) 
when compared to that of the control group. The 
increase in the HFHF group was 77.4% and 30.9% 
compared to that of the HFD, HFruD groups.
In addition, the mean values of TBARS were sig-
nificantly increased by 122% (1.22 folds), 175% (1.75 
folds) and 325% (2.29 folds), respectively, when com-
pared to that of the control group. The increase in 
the HFHF group was 48.2% and 54.5% compared to 
that of the HFD, HFruD groups. 
Table 4. Biochemical parameters of the studied groups 
Group Hepatic TG 
[µmmol/gprot]
Serum TG 
[mg/dL]
TC 
[mg/dL]
HDL-C 
[mmol/L]
LDL-C 
[mmol/L]
Albumin 
[g/dL]
Glucose 
[mmol/L]
Control Mean ± SD 49.3± 3.1 68.7 ± 4.2 131.7 ± 3.1 61.0 ± 2.0 57.3 ± 3.9 5.5 ± 0.3 89.0 ± 11.8
HFD Mean ± SD 90.0 ± 5.0 108.7 ± 7.6 208.3 ± 17.2 25.3 ± 9.3 160.7 ± 7.3 3.9 ± 0.7 165.0 ± 9.2
Versus control 0.000* 0.000* 0.000* 0.000* 0.000* 0.01* 0.000*
Versus HFruD 0.007* 0.183 0.162 1.000 0.011* 1.000 0.197
Versus HFHF 0.014* 0.227 0.008 1.000 0.002* 0.211 0.008*
HFruD Mean ± SD 74.0 ± 3.6 96.0 ± 6.6 187.0 ± 7.8 32.3 ± 5.5 134.9 ± 4.3 4.4 ± 0.4 182.7 ± 6.8
Versus control 0.000* 0.003* 0.001* 0.002* 0.000* 0.06 0.000*
Versus HFD 0.007* 0.183 0.162 1.000 0.011* 1.000 0.197
Versus HFHF 0.000* 0.006* 0.000 0.978 0.000* 0.036* 0.335
HFHF Mean ± SD 104.3 ± 4.0 120.7 ± 4.7 246.3 ± 2.5 25.0 ± 4.0 193.9 ± 10.3 3.0 ± 0.1 198.0 ± 3.6
Versus control 0.000* 0.000* 0.000* 0.000* 0.000* 0.001* 0.000*
Versus HFD 0.014* 0.227 0.008 1.000 0.002* 0.211 0.008*
Versus HFruD 0.000* 0.006* 0.000 0.978 0.000* 0.036* 0.335
*p-value significant; HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol; TC — total cholesterol; TG — triglyceride; SD — standard deviation; other 
abbreviations — see text
Table 3. Area per cent of collagen fibres, inducible nitric oxide synthase (iNOS), alpha-smooth muscle actin (α-SMA) and optical density 
of periodic acid-Schiff (PAS) among the different groups
Group Area per cent of collagen PAS optical density α-SMA iNOS
Control Mean ± SD 1.47 ± 0.64 0.26 ± 0.01 3.0 ± 1.0 3.1 ± 0.8
HFD Mean ± SD 6.03 ± 0.45 0.17 ± 0.04 16.0 ± 1.9 26.0 ± 2.0
Versus control 0.000* 0.000* 0.000* 0.000*
Versus HFruD 1.000 0.007* 0.005* 0.027*
Versus HFHF 0.315 0.000* 0.001* 0.000*
HFruD Mean ± SD 5.97 ± 0.68 0.13 ± 0.02 8.2 ± 1.7 31.1 ± 1.7
Versus control 0.000* 0.000* 0.054 0.000*
Versus HFD 1.000 0.007* 0.005* 0.027*
Versus HFHF 0.385 0.007* 0.000* 0.000*
HFHF Mean ± SD 4.85 ± 0.73 0.09 ± 0.01 25.5 ± 2.5 48.3 ± 1.7
Versus control 0.001* 0.000* 0.000* 0.000*
Versus HFD 0.315 0.007* 0.001* 0.000*
Versus HFruD 0.385 0.000* 0.000* 0.000*
*p-value significant; SD — standard deviation; other abbreviations — see text
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On the other hand, the mean levels of SOD in 
the HFD, HFruD and HFHF groups exhibited 24%, 
46%, and 70% decrease compared to that of the 
control group. The decrease in the HFHF group was 
60.9% and 44.4% compared to that of the HFD, 
HFruD groups.
In addition, the mean values of GSH decreased 
significantly by 34%, 48%, and 62%, respectively, 
compared to that of the control group. The decrease 
in the HFHF group was 43% and 27.3% compared to 
that of the HFD, HFruD groups. 
BCL-2, Bax, BCL-2/Bax ratio and caspase 3 (Table 6)
Non-significant changes occurred in the BCL-2 
among the different groups.
The mean value of the Bax in the HFD, HFruD 
and HFHF groups increased by 460% (4 folds), 580% 
(5 folds) and 660% (6 folds); while the mean values 
of the BCL-2/Bax ratio in these groups decreased by 
33% when compared to that of the control group.
The mean value of the caspase 3 in the HFD, HFruD 
and HFHF groups increased by 130%, 169%, and 
207% when compared to that of the control group.
Table 5. Inflammatory and oxidative/antioxidative markers in the different studied groups 
Group TNF-α 
[g/mL]
IL-6 
[g/mL]
MDA  
[nmol/mg protein]
TBARS 
[nmol/mg protein]
SOD 
[U/mg protein]
GSH  
[U/mg protein]
Control Mean ± SD 37.5 ± 5.3 18.7 ± 3.2 5.0 ± 2.0 20.0 ± 10.0 84.0 ± 5.3 144.0 ± 2.0
HFD Mean ± SD 84.6 ± 12.2 61.7 ± 7.6 31.3 ± 3.2 44.3 ± 5.0 64.0 ± 3.6 95.0 ± 5.0
Versus control 0.000* 0.000* 0.000* 0.01* 0.005* 0.000*
Versus HFruD 0.020* 0.001* 0.024* 0.504 0.007* 0.002*
Versus HFHF 0.001* 0.000* 0.000* 0.000* 0.000* 0.000*
HFruD Mean ± SD 108.8 ± 4.7 90.3 ± 5.5 42.3 ± 2.5 55.0 ± 5.0 45.0 ± 5.0 74.7 ± 4.5
Versus control 0.000* 0.000* 0.000* 0.001* 0.000* 0.000*
Versus HFD 0.020* 0.001* 0.024* 0.504 0.007* 0.002*
Versus HFHF 0.236 0.571 0.011* 0.003* 0.005* 0.002*
HFHF Mean ±SD 123.2 ± 2.9 98.3 ± 2.9 55.0 ± 5.0 85.0 ±  5.0 25.0 ± 5.0 54.3 ± 4.0
Versus control 0.000* 0.000* 0.000* 0.000* 0.000* 0.000*
Versus HFD 0.001* 0.000* 0.000* 0.000* 0.000* 0.000*
Versus HFruD 0.236 0.571 0.011* 0.003* 0.005* 0.002*
*p-value significant; GSH — glutathione; Il-6 — interleukin 6; MDA — malondialdehyde; SD — standard deviation; SOD — superoxide dismutase; TBARS — thiobarbituric acid reactive 
substances; TNF-α — tumour necrosis factor alpha; other abbreviations — see text
Table 6. BCL-2, Bax, BCL-2/Bax ratio and caspase 3 among the different groups
Group BCL-2 Bax BCL-2/Bax ratio Caspase 3
Control Mean ± SD 0.8 ± 0.2 0.25 ± 0.03 0.9 ± 0.1 1.3 ± 0.3
HFD Mean ± SD 0.9 ± 0.1 1.4 ± 0.1 0.6 ± 0.0 3.0 ± 0.5
Versus control 1.000 0.003* 0.02* 0.006*
Versus HFruD 1.000 0.099 1.000 1.000
Versus HFHF 0.400 0.004* 1.000 0.095
HFruD Mean ± SD 1.0 ± 0.1 1.7 ± 0.2 0.6 ± 0.1 3.5 ± 0.4
Versus control 0.600 0.000* 0.01* 0.001*
Versus HFD 1.000 0.099 1.000 1.000
Versus HFHF 1.000 0.318 1.000 0.800
HFHF Mean ± SD 1.1 ± 0.1 1.9 ± 0.1 0.6 ± 0.1 4.0 ± 0.5
Versus control 0.100 0.000* 0.009* 0.000*
Versus HFD 0.400 0.004* 1.000 0.095
Versus HFruD 1.000 0.318 1.000 0.800
*p-value significant; SD — standard deviation; other abbreviations — see text
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Figure 5. The immunoreaction of the and alpha-smooth muscle actin (α-SMA; arrows) in different groups; A. Slight reaction in the control group; 
B–D. Strong reaction in the HFD, HFruD and HFHF groups respectively. The immunohistochemical visualisation of α-SMA was performed as 
described in methods. Scale bars = 50 µm, total magnification ×400.
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Figure 4. Liver sections showing the periodic acid-Schiff (PAS) reaction (arrows) in different groups; A. Strong PAS reaction in the control group; 
B–D. Decreased PAS reaction in the HFD, HFruD and HFHF groups, respectively. PAS staining. Scale bars = 50 µm, total magnification ×400.
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Figure 6. The immunoreaction of the inducible nitric oxide synthase (iNOS; arrows) in different groups (×400); A. No reaction in the control 
group; B–D. Strong reaction in the HFD, HFruD and HFHF groups respectively. The immunohistochemical visualisation of iNOS was performed 
as described in methods. Scale bars = 50 µm, total magnification ×400.
A non-significant difference of Bax, BCL-2/Bax and 
caspase 3 was observed in the HFD, HFruD and HFHF 
groups when compared to each other. 
DISCUSSION
The HFD, HFruD and HFHF groups developed 
a significant increase in weight gain. Such weight 
gain is mostly due to the gradual accumulation in 
body fat [21]. Obesity is a key feature of the MS [2]. 
The HFD, HFruD and HFHF groups developed ‘inter-
nal’ metabolic impairments including elevated serum 
levels of albumin, glucose, TG, LDL. In addition, the 
level of HDL was decreased. 
The HFD, HFruD and HFHF groups developed 
a cluster of liver disorders ranging from steatosis to 
necrosis and inflammation (NASH). All these features 
are named collectively NAFLD [3]. Observed only in 
the HFD and HFHF groups, ballooned hepatocytes are 
delimited to the most severe form of hepatic injury 
and indicate cell necrosis [7].
The chief factor of hepatic injury is lipid build-up in 
liver cells [7]. Fat accumulation in the liver plays a criti-
cal role in the initiation and progression of NAFLD [22].
The other major cause of hepatic injury is the oxida-
tive stress [28]. Oxidative stress was developed in three 
Western diet groups being highest in the HFHF group. It 
is defined as the shift in the balance between oxidants 
and antioxidants in favour of oxidants [5, 6]. The oxidant 
markers (MDA and TBARS) were elevated, while the 
antioxidant markers (SOD and GSH) were decreased in 
all Western diet groups. The oxidative stress is mostly 
caused by the developed obesity [41]. In NAFLD progres-
sion, the “two-hit” theory is generally established [11]. 
The first hit is lipid accumulation in the hepatocytes and 
the second hit is oxidative stress-induced lipotoxicity, 
which stimulates cellular injury leading to NASH [26].
The other possible cause of hepatic injury is the 
elevation of the iNOS. The iNOS increased 7.6 folds 
in HFD group, 9 folds in HFruD and 14 folds in HFHF 
group. The NO-derived from iNOS appears to induce 
inflammation and oxidative stress [10]. These events 
create a deleterious environment that ultimately leads 
to cellular damages.
Steatosis observed in the Western diet groups 
may be due to the taken nutrition above the packing 
capability of adipose tissue which results in precip-
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itation of TG in the liver [38]. Steatosis may be also 
correlated with the observed increased expression of 
iNOS in such groups [17].  
Inflammation was observed around the periportal 
area. In addition, the TNF-α and IL-6 were elevated in 
the HFD, HFruD and HFHF groups being highest in the 
HFHF group. Obesity has been found to release these 
inflammatory cytokines from fat [14]. In addition, in-
creased apoptosis could be an important mechanism 
leading to inflammation in the liver [39]. Fructose in 
the HFruD and HFHF groups facilitates the inflamma-
tion through the increase in the lipopolysaccharides 
influx from the gut [24]. Such increase induces intra-
hepatic innate immunity and ROS production [31]. In 
addition, fructose promotes the hepatic inflammation 
through augmented gut endotoxin-mediated Kupffer 
cells activation [18].
The area per cent of collagen fibres was elevated 
in the HFD, HFruD and HFHF groups being higher in 
the first two groups. Hepatic fibrosis is one of the 
main features of NASH [21] and represents the later 
stages of NAFLD [34]. The degree of TG deposition is 
predictive of the severity of the fibrosis [34]. The de-
gree of fibrosis was evaluated by using the α-SMA [4]. 
The highest elevation was observed in the HFHF 
(7.5 folds), followed by the HFD group (4 folds), 
followed finally by the HFruD (1.7 folds).
Hepato-cellular apoptosis has been identified 
in the HFD, HFruD and HFHF groups. Apoptosis is 
a prominent feature of NASH [14, 27] and is a key 
component in the pathogenesis, development, and 
progression of the NASH [27]. The framework of 
the apoptotic signal pathway appears to be sever-
al pro-apoptotic signals which eventually converge 
into a common mechanism driven by caspases [35]. 
Caspase is a unique set of cysteine proteases that 
cleave critical cellular proteins [35]. Caspase 3 is the 
key killer of apoptosis, thus promoting cell survival 
[23]. The value of the caspase 3 increased markedly 
in the HFD, HFruD and HFHF groups. 
The caspases mechanism is negatively regulated 
by the BCL-2 family [1]. The BCL-2 family is classified 
into three subfamilies: a subfamily including BCL-2, 
a subfamily including Bax and Bak and a subfamily 
including Bik and Bid [37]. BCL-2 exerts anti-apop-
totic activity by blocking a step which leads to the 
activation of caspases, while Bax exerts proapoptotic 
activity [37]. The ratio between anti-apoptotic and 
pro-apoptotic members of the BCL-2 family defines 
the liability of the cell to apoptosis [37]. As observed 
from our finding, non-significant changes occurred in 
BCL-2, while the value of Bax increased dramatically in 
all Western diet groups, especially in the HFHF group. 
Finally, the values of the BCL-2/Bax ratio decreased in 
all Western diet groups.
CONCLUSIONS
In conclusion, HFD, HFruD, and HFHF developed 
morphologic hepatic changes ranging from steatosis 
to necrosis and inflammation, besides the develop-
ment of internal metabolic impairments. The chief 
factors of hepatic injury were fat accumulation in 
the hepatocytes, oxidative stress and highly elevated 
iNOS. Compared to the other groups, HFHF’s effect 
was more prominent.
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